Skip to main content
logo
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
4.020
-0.050 (-1.23%)
At close: Sep 22, 2026, 4:00 PM EDT
4.030
+0.010 (0.25%)
After-hours: Sep 22, 2026, 7:30 PM EDT

Seres Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.465.70.14-113.72-250.16-65.58
Depreciation & Amortization
11.8512.5314.676.246.635.95
Other Amortization
--1.411.140.712.53
Loss (Gain) From Sale of Assets
-0.05-0.19-146.39---
Asset Writedown & Restructuring Costs
5.81-3.27---
Loss (Gain) From Sale of Investments
----0.240.690.5
Stock-Based Compensation
9.1910.8420.9734.125.4820.22
Other Operating Activities
0.110.0222.8414.16.231.54
Change in Accounts Receivable
-24.391.556.61-8.67-9.39
Change in Inventory
---33.8-29.65--
Change in Accounts Payable
-1.01-2.4-2.94-11.582.29.36
Change in Unearned Revenue
---4.126.41-7.13-4.36
Change in Other Net Operating Assets
-30.3-26.93-31.26-15.48-13.4727.14
Operating Cash Flow
-51.261.12-148.61-117.35-228.826.69
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.04-0.25-0.38-7.98-9.82-9.57
Sale of Property, Plant & Equipment
0.220.21----
Divestitures
--141.27---
Investment in Securities
---18.5692.2573.65
Other Investing Activities
--1.4---
Investing Cash Flow
0.19-0.04142.2910.5882.4364.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---103.3827.61-
Long-Term Debt Repaid
---127.91-52.86-1.91-0.95
Net Debt Issued (Repaid)
---127.9150.5225.7-0.95
Issuance of Common Stock
14.8613.937.5321.19103.92.13
Financing Cash Flow
14.8613.9-90.3771.71129.61.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
---00-0-0
Miscellaneous Cash Flow Adjustments
----0-
Net Cash Flow
-36.2114.97-96.69-35.07-16.7971.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-51.30.87-148.99-125.33-238.64-2.88
Free Cash Flow Growth
------
Free Cash Flow Margin
-2724.11%109.63%----1.99%
Free Cash Flow Per Share
-5.500.10-19.18-19.58-44.16-0.63
Levered Free Cash Flow
-64.6-54.96-60.11-112.46-87.8214.04
Unlevered Free Cash Flow
-64.6-54.96-61.52-112.06-84.7713.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--10.8612.554.932.45
Change in Working Capital
-55.7-27.78-65.51-58.98-18.3941.53
SEC Filings: 10-K · 10-Q